Net sales for Q1 2026 reached $27.6 million, a 57% increase compared to $17.6 million in Q1 2025. Net loss for the quarter was $21.8 million, compared to a net loss of $28.7 million in the prior year period. Gross margin improved to 59% in Q1 2026 from 51% in Q1 2025, reflecting increased production scale and cost absorption. Operating expenses rose to $40.7 million, up 47% year-over-year, primarily due to increased headcount and R&D investments. The company maintains a strong liquidity position with $239.5 million in cash, cash equivalents, and investments as of March 31, 2026.